You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-CD45RO antibody [UCHL1] (FITC) (ab51564)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-CD45RO antibody [UCHL1] (FITC)
See all CD45RO products (9) ...

Description

Mouse monoclonal [UCHL1] to CD45RO (FITC)

Conjugation

FITC

Conjugation notes

The antibody is conjugated with fluorescein isothiocyanate isomer 1 (FITC). The molecular F/P ratio is between 5 and 10.

Specificity

ab51564 is directed against the CD45RO antigen (restricted T200, gp180), a component of the Leukocyte Common Antigen (LCA) complex, which is expressed on human T lymphocytes (40% of CD4 and 20% of CD8 positive T lymphocytes), most thymocytes and the majority of T cell malignancies. ab51564 also reacts weak with most human granulocytes and monocytes, and reacts hardly with B lymphocytes, NK cells or thrombocytes.

Tested applications

Flow Cyt, ICC/IFmore details

Cross reactivity

Reacts with

Human

Immunogen

T cell line CA1 (Human)

Positive control

CD45RO positive cells in peripheral blood.

Properties

Form

Liquid

Storage instructions

Store at +4°C in the dark. Do not freeze.

Storage buffer

Preservative: 0.1% Sodium Azide
Constituents: 1% BSA, PBS

Concentration

Concentration information loading...

Purity

Ion Exchange Chromatography

Purification notes

The antibody was purified from ascites using column chromatography

Primary antibody notes

This antibody would be useful for enumeration of CD45RO positive cells in peripheral blood.

Clonality

Monoclonal

Clone number

UCHL1

Myeloma

NS1

Isotype

IgG2a

  • Flow Cytometry-Anti-CD45RO antibody [UCHL1] (FITC)(ab51564)Flow Cytometry-Anti-CD45RO antibody [UCHL1] (FITC)(ab51564) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab51564 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN. Dephosphorylates LYN, and thereby modulates LYN activity.

Involvement in disease

Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain.

Sequence similarities

Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.
Contains 2 fibronectin type-III domains.
Contains 2 tyrosine-protein phosphatase domains.

Domain

The first PTPase domain interacts with SKAP1.

Post-translational
modifications

Heavily N- and O-glycosylated.

Cellular localization

Membrane. Membrane raft. Colocalized with DPP4 in membrane rafts.

Target information above from: UniProt accessionP08575 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • B220 antibody
  • CD45 antibody
  • cd45 antigen antibody
  • GP180 antibody
  • L-CA antibody
  • lca antibody
  • Leukocyte common antigen antibody
  • LY 5 antibody
  • LY5 antibody
  • Ptprc antibody
  • PTPRC_HUMAN antibody
  • Receptor-type tyrosine-protein phosphatase C antibody
  • T200 antibody
  • T200 glycoprotein antibody
see all

Anti-CD45RO antibody [UCHL1] (FITC) images:

  Flow Cytometry-Anti-CD45RO antibody [UCHL1] (FITC)(ab51564)

Flow Cytometry-Anti-CD45RO antibody [UCHL1] (FITC)(ab51564)

Overlay histogram showing peripheral blood lymphocytes stained with ab51564 (red line). The cells incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab51564, 1 µl/1x106 cells) for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a FITC (1 µg/1x106 cells ) for 30 min at 22°C. Acquisition of >5,000 events was performed.

References for Anti-CD45RO antibody [UCHL1] (FITC) (ab51564)

ab51564 has not yet been referenced specifically in any publications.

Publishing research using ab51564? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"